Featured Research

from universities, journals, and other organizations

Study of over 450,000 women finds 3-D mammography detects more invasive cancers and reduces call-back rates

Date:
June 24, 2014
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
Researchers have found that 3D mammography —- known as digital breast tomosynthesis —- found significantly more invasive, or potentially lethal, cancers than a traditional mammogram alone and reduced call-backs for additional imaging.

Emily F. Conant, MD.
Credit: Image courtesy of Perelman School of Medicine at the University of Pennsylvania

Reporting in the June 25 issue of JAMA, researchers from Penn Medicine and other institutions found that 3D mammography -- known as digital breast tomosynthesis -- found significantly more invasive, or potentially lethal, cancers than a traditional mammogram alone and reduced call-backs for additional imaging. This is the largest study reported to date -- with nearly a half a million women -- measuring the effectiveness of the technology, and could potentially lead to a change in the standard of care for breast screening.

"It's the most exciting improvement to mammography that I have seen in my career, even more important for women than the conversion from film-screen mammography to digital mammography," said senior author Emily F. Conant, MD, chief of Breast Imaging the department of Radiology at the Perelman School of Medicine at the University of Pennsylvania. "3D mammography finds more clinically significant breast cancers earlier, which is the key so that women have more treatment options and ultimately better health outcomes."

In the retrospective study, the researchers looked at 281,187 digital mammography examinations and 173,663 examinations with both tomosynthesis and digital mammography between 2010 and 2012. The data set included women from a wide range of breast cancer screening programs that were both geographically diverse and included both academic and community practices, 13 in total.

Researchers found 41 percent more invasive cancers when women were screened with tomosynthesis plus digital compared to digital mammography alone. The use of tomosynthesis also reduced the number of women called back for additional screenings by 15 percent.

Conventional digital mammography is the most widely-used screening modality for breast cancer, but may yield suspicious findings that turn out not to be cancer, known as false-positives. Such findings are associated with a higher recall rate, or the rate at which women are called back for additional imaging or biopsy that may be deemed unnecessary.

Tomosynthesis, however, allows for 3-D reconstruction of the breast tissue, giving radiologists a clearer view of the overlapping slices of breast tissue. And though a relatively new technology, it has shown promise at reducing recall rates in all groups of patients, including younger women and those with dense breast tissue, and better detection rates in smaller studies. In 2011, tomosynthesis was approved by the U.S. Food and Drug Administration to be used in combination with standard digital mammography for breast cancer screening.

3D mammography is the only method used for breast cancer imaging that has demonstrated this combined benefit, the authors report. While 3D mammography found more invasive cancers, detection of in situ cancers (non-invasive cancers) was similar to a traditional mammography.

Since October 2011, all screening mammograms at Penn Medicine's Perelman Center for Advanced Center now include tomosynthesis according to Dr. Conant.

"The coming years will be very exciting, as we see further improvements in this innovative technology," said Conant. "This new technology will certainly change the way we screen women."

The study also included lead author Sarah M. Friedewald, MD, of the Caldwell Breast Center at Advocate Lutheran General Hospital; Elizabeth Rafferty, MD; Stephen L. Rose, MD; Melissa Durand, MD; Donna Plecha, MD; Julianne Greenberg, MD; Mary K. Hayes, MD; Debra S. Copit, MD; Kara Carlson, MD; Thomas Cink, MD; Lora Barke, MD; Linda Greer, MD; and David Miller, MS.

For this research, Dr. Conant received a grant from the National Cancer Institute (5U54CA163316-03.)


Story Source:

The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.


Journal Reference:

  1. Seth S. Martin, Michael J. Blaha, Mohamed B. Elshazly, Peter P. Toth, Peter O. Kwiterovich, Roger S. Blumenthal, Steven R. Jones. Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile. JAMA, 2013; 310 (19): 2061 DOI: 10.1001/jama.2013.280532

Cite This Page:

Perelman School of Medicine at the University of Pennsylvania. "Study of over 450,000 women finds 3-D mammography detects more invasive cancers and reduces call-back rates." ScienceDaily. ScienceDaily, 24 June 2014. <www.sciencedaily.com/releases/2014/06/140624215113.htm>.
Perelman School of Medicine at the University of Pennsylvania. (2014, June 24). Study of over 450,000 women finds 3-D mammography detects more invasive cancers and reduces call-back rates. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/06/140624215113.htm
Perelman School of Medicine at the University of Pennsylvania. "Study of over 450,000 women finds 3-D mammography detects more invasive cancers and reduces call-back rates." ScienceDaily. www.sciencedaily.com/releases/2014/06/140624215113.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins